ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004

Breast Cancer Progress Report Summaries

November 14, 1975

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

June 28, 2002

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000